136 related articles for article (PubMed ID: 31889475)
1. Addition of docosahexaenoic acid synergistically enhances the efficacy of apatinib for triple-negative breast cancer therapy.
Ma Y; Yu J; Li Q; Su Q; Cao B
Biosci Biotechnol Biochem; 2020 Apr; 84(4):743-756. PubMed ID: 31889475
[TBL] [Abstract][Full Text] [Related]
2. Apatinib enhanced anti-tumor activity of cisplatin on triple-negative breast cancer through inhibition of VEGFR-2.
Gao Z; Shi M; Wang Y; Chen J; Ou Y
Pathol Res Pract; 2019 Jul; 215(7):152422. PubMed ID: 31079851
[TBL] [Abstract][Full Text] [Related]
3. Astragalus polysaccharide enhanced antitumor effects of Apatinib in gastric cancer AGS cells by inhibiting AKT signalling pathway.
Wu J; Yu J; Wang J; Zhang C; Shang K; Yao X; Cao B
Biomed Pharmacother; 2018 Apr; 100():176-183. PubMed ID: 29428665
[TBL] [Abstract][Full Text] [Related]
4. Apatinib inhibits glycolysis by suppressing the VEGFR2/AKT1/SOX5/GLUT4 signaling pathway in ovarian cancer cells.
Chen L; Cheng X; Tu W; Qi Z; Li H; Liu F; Yang Y; Zhang Z; Wang Z
Cell Oncol (Dordr); 2019 Oct; 42(5):679-690. PubMed ID: 31325096
[TBL] [Abstract][Full Text] [Related]
5. Docosahexaenoic acid suppresses migration of triple-negative breast cancer cell through targeting metastasis-related genes and microRNA under normoxic and hypoxic conditions.
Javadian M; Shekari N; Soltani-Zangbar MS; Mohammadi A; Mansoori B; Maralbashi S; Shanehbandi D; Baradaran B; Darabi M; Kazemi T
J Cell Biochem; 2020 Mar; 121(3):2416-2427. PubMed ID: 31713924
[TBL] [Abstract][Full Text] [Related]
6. The omega-3 polyunsaturated fatty acid docosahexaenoic acid inhibits proliferation and progression of non-small cell lung cancer cells through the reactive oxygen species-mediated inactivation of the PI3K /Akt pathway.
Yin Y; Sui C; Meng F; Ma P; Jiang Y
Lipids Health Dis; 2017 May; 16(1):87. PubMed ID: 28468627
[TBL] [Abstract][Full Text] [Related]
7. Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2/RAF/MEK/ERK and PI3K/AKT pathways in cholangiocarcinoma cell.
Huang M; Huang B; Li G; Zeng S
BMC Gastroenterol; 2018 Nov; 18(1):169. PubMed ID: 30400838
[TBL] [Abstract][Full Text] [Related]
8. Apatinib enhances chemosensitivity of acute myeloid leukemia hl60 cells to cytarabine by inducing apoptosis.
Pan Q; Wang J; Jiang X; Yang E; Dong L; Gu K
J BUON; 2019; 24(1):374-381. PubMed ID: 30941994
[TBL] [Abstract][Full Text] [Related]
9. Apatinib-induced protective autophagy and apoptosis through the AKT-mTOR pathway in anaplastic thyroid cancer.
Feng H; Cheng X; Kuang J; Chen L; Yuen S; Shi M; Liang J; Shen B; Jin Z; Yan J; Qiu W
Cell Death Dis; 2018 Oct; 9(10):1030. PubMed ID: 30301881
[TBL] [Abstract][Full Text] [Related]
10. Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer.
Hu X; Zhang J; Xu B; Jiang Z; Ragaz J; Tong Z; Zhang Q; Wang X; Feng J; Pang D; Fan M; Li J; Wang B; Wang Z; Zhang Q; Sun S; Liao C
Int J Cancer; 2014 Oct; 135(8):1961-9. PubMed ID: 24604288
[TBL] [Abstract][Full Text] [Related]
11. Role of docosahexaenoic acid in enhancement of docetaxel action in patient-derived breast cancer xenografts.
Newell M; Goruk S; Mazurak V; Postovit L; Field CJ
Breast Cancer Res Treat; 2019 Sep; 177(2):357-367. PubMed ID: 31236812
[TBL] [Abstract][Full Text] [Related]
12. Oxidized derivative of docosahexaenoic acid preferentially inhibit cell proliferation in triple negative over luminal breast cancer cells.
Pogash TJ; El-Bayoumy K; Amin S; Gowda K; de Cicco RL; Barton M; Su Y; Russo IH; Himmelberger JA; Slifker M; Manni A; Russo J
In Vitro Cell Dev Biol Anim; 2015 Feb; 51(2):121-7. PubMed ID: 25413005
[TBL] [Abstract][Full Text] [Related]
13. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051
[No Abstract] [Full Text] [Related]
14. α-linolenic acid and docosahexaenoic acid, alone and combined with trastuzumab, reduce HER2-overexpressing breast cancer cell growth but differentially regulate HER2 signaling pathways.
Mason JK; Klaire S; Kharotia S; Wiggins AK; Thompson LU
Lipids Health Dis; 2015 Aug; 14():91. PubMed ID: 26282560
[TBL] [Abstract][Full Text] [Related]
15. Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma.
Liao J; Jin H; Li S; Xu L; Peng Z; Wei G; Long J; Guo Y; Kuang M; Zhou Q; Peng S
J Exp Clin Cancer Res; 2019 Nov; 38(1):454. PubMed ID: 31694662
[TBL] [Abstract][Full Text] [Related]
16. Apatinib inhibits the proliferation of gastric cancer cells via the AKT/GSK signaling pathway
Chen Y; Chen N; Xu J; Wang X; Wei X; Tang C; Duanmu Z; Shi J
Aging (Albany NY); 2021 Aug; 13(16):20738-20747. PubMed ID: 34453028
[TBL] [Abstract][Full Text] [Related]
17. Enhanced anticancer properties of lomustine in conjunction with docosahexaenoic acid in glioblastoma cell lines.
Harvey KA; Xu Z; Saaddatzadeh MR; Wang H; Pollok K; Cohen-Gadol AA; Siddiqui RA
J Neurosurg; 2015 Mar; 122(3):547-56. PubMed ID: 25526274
[TBL] [Abstract][Full Text] [Related]
18. Docosahexaenoic acid reduces sterol regulatory element binding protein-1 and fatty acid synthase expression and inhibits cell proliferation by inhibiting pAkt signaling in a human breast cancer MCF-7 cell line.
Huang LH; Chung HY; Su HM
BMC Cancer; 2017 Dec; 17(1):890. PubMed ID: 29282029
[TBL] [Abstract][Full Text] [Related]
19. [Effects of docosahexaenoic acid on cell apoptosis, invasion and migration of cervical cancer cells in vitro].
Yang C; Zhang GP; Chen YN; Meng FL; Liu SS; Gong SP
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun; 36(6):848-56. PubMed ID: 27320891
[TBL] [Abstract][Full Text] [Related]
20. Multicenter phase II study of apatinib in non-triple-negative metastatic breast cancer.
Hu X; Cao J; Hu W; Wu C; Pan Y; Cai L; Tong Z; Wang S; Li J; Wang Z; Wang B; Chen X; Yu H
BMC Cancer; 2014 Nov; 14():820. PubMed ID: 25376790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
